BioLegend

Founded in 2002, BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research. With a state-of-the-art facility, Biolegend’s mission is to accelerate research and discovery by providing the highest quality products. Biolegend’s expertise covers immunology, neuroscience, cancer, stem cells and cell biology.

Europa Biosite’s subsidiaries distribute for BioLegend in Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway and Sweden.